The prognosis for those with hyper-acute hepatic failure is best, often as high as 50%, with maximal medical care. 4 In contrast, the prognosis for survival without liver transplantation for those with subacute and lateonset hepatic failure is poorest, often cited as low as zero. The prognosis for those with acute hepatic failure lies between these two extremes in prognosis for survival without liver transplantation and is intermediate in value, at approximately 15%-20%. 4 
Clinical management
The medical management of patients with fulminant hepatic failure requires aggressive attention to detail, and invasive monitoring that necessitates admission to an intensive care unit (ICU). Accurate and frequent (often hourly) measures of intake, output, blood pressure, pulse, respiratory rate, and pH; as well as blood sugar, lactic acid, and electrolytes, to include calcium, phosphorus, and magnesium; renal functional measures; coagulation parameters; and measures of intravascular fibrinolysis, as well as intra-cranial pressure (ICP) monitoring, are required in adults. 5 In children, clinical measures of the level of consciousness and the neurologic status are sufficient, and are usually assessed without placement of an ICP monitoring device. This is because children typically have loose cranial sutures, and those who are less than 2 years of age often have open fontanels, allowing dissipation of any increase in ICP. 6 Measures that can be used to maintain ICP within acceptable ranges include the infusion of 10% dextrose, mannitol, and large amounts of magnesium, phosphorous, and potassium, as well as elevating the head of the bed. Every attempt should be made to maintain the cerebral perfusion pressure greater than 50 mmHg, and Key words: fulminant hepatic failure, liver transplantation, acute hepatic failure
Definitions
Fulminant hepatic failure was initially described by Trey as a syndrome in which an individual without prior biochemical or clinical evidence of liver disease develops jaundice (the usual first overt sign of liver disease) that then progresses to hepatic coma (grade 2-4 encephalopathy) within 2 weeks or less. 1 More recently, the syndrome has been redefined and amended by the French and British groups to include the concepts of acute and subacute hepatic failure, as well as hyperacute, acute, and late-onset hepatic failure.
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Etiology and prognosis
These later distinctions in nomenclature were created on the basis of etiology and prognosis. Individuals with hyper-acute hepatic failure typically have either hepatitis A or B (and possibly hepatitis E in parts of the world where hepatitis E is prevalent) as the principal cause of the condition, accounting for 60% of the total cases of fulminant hepatic failure. The principal causes of acute hepatic failure are also hepatitis A and B, but also include cases of acetaminophen hepatotoxity. In contrast, cases of subacute hepatic failure and, to greater degree, cases of late-onset hepatic failure present as cases of drug-induced hepatic failure other than acetaminophen hepatotoxity, and as cases of putative non-A non-B non-C hepatitis. 4 ICP less than 30 mmHg. 4, 5, 7 These pressures are defined by the following equation. The mean arterial pressure (MAP) minus ICP equals the cerebral perfusion pressure (CPP). 4, 6, 7 Elevating the head of the bed and mannitol infusions are the principal measures used to control ICP. The MAP can be regulated with dopamine, often at renal doses. Higher doses may lead to cardiac arrhythmias, necessitating the use of adrenergic agents such as levophed (norepinephrine bitartrate). The requirement for levophed can lead to peripheral tissue hypoxia and lactic acidosis, as a consequence of increased production of lactic acid rather than a failure to clear lactic acid by the liver. This scenario necessitates the use of large volumes of sodium bicarbonate or the use of artificial buffers such as THAM (trometamol; tris-hydroxymethyl aminomethane). Intra-cranial monitoring devices, when used, should be placed prospectively as the patient becomes lethargic in stage 2 hepatic encephalopathy and not urgently when the patient is in stage 4 coma. 6, 7 This often necessitates placement of such a device at the time that the patient is admitted to the ICU. A coagulopathy should not prohibit the placement of an extradural ICP monitoring device, unless the prothrombin time is more than 30 s. 4, 6, 7 In order to maintain renal function, an infusion of dopamine (less than 10 µg/kg per min) is often required. As well as these attempts to maintain overall homeostasis in the face of severe liver injury, the use of ultrafiltration, hemodialysis, hemo-filtration coupled with hemodialysis, and plasmapheresis can be added in patients with advanced liver injury. 4, 8 The administration of fresh frozen plasma solely for the purpose of correcting coagulation deficits is limited to individuals who have prothrombin times in excess of 50 s.
In addition to intra-cranial hypertension, infection and gastrointestinal bleeding are frequent lethal complications of fulminant hepatic failure. [2] [3] [4] Both require close monitoring, and frequent cultures of blood, urine, sputum, and other fluids, as well as cultures from sites at which intra-vascular monitoring devices or infusion lines are located. Antibiotic prophylaxis with broadspectrum antibiotics such as a third generation cephalosporin and an antifungal agent, typically diflucan, is routine in such patients. Infections with either bacteria or fungi (often both) can occur in the absence of fever and/or leukocytosis in patients with fulminant hepatic failure. The use of an intravenous H 2 blocker or the oral administration of a proton pump inhibitor is also routine.
In our unit, we insist upon a transvenous liver biopsy within 24 h of admission to the ICU in all patients with fulminant hepatic failure. Moreover, in those patients with biochemical evidence of renal failure or disease, we also obtain a simultaneous transvenous renal biopsy.
The liver biopsy is used to gauge the severity of the hepatic injury, as being 60%, 70%, 80%, or 90% necrosis. It is also used to assess the liver for evidence of regeneration, as manifested by the presence of liver cell mitosis. In general, patients with 60% or less necrosis are likely to survive without the need for transplantation, while those with 90% or more necrosis are not going to survive without transplantation. [2] [3] [4] Those patients that have hepatic necrosis greater than 60% but less than 90% have a less clear prognosis and require the most aggressive care and attention. In rare cases, the liver biopsy can provide etiologic information that enables specific therapy to be instituted, as in the case of herpes, cytomegalovirus, adenovirus, and, possibly, paramyxovirus hepatitis infections. Because of the variable nature of liver biopsies in patients with fulminant hepatic failure, a minimum of three, and ideally six, biopsies of the hepatic parenchyma should be obtained for histologic evaluation. In addition, in patients in whom Wilson's disease or hepatic iron toxicity is possible, a separate core of liver tissue should be obtained for hepatic iron and copper determinations.
The renal biopsies are useful in determining whether or not a liver and kidney transplant should be anticipated, as contrasted to an isolated liver transplant. Histologic evidence of pre-existing glomerulonephritis or renal vascular disease would indicate combined transplantation, whereas the absence of histological renal disease suggests that the renal dysfunction present is due to the hepato-renal syndrome or pre-renal causes, and as a result, there will be no need for renal transplantation.
Clearly, not all patients with fulminant hepatic failure will require a liver transplant. Most of those with less than 60% necrosis certainly will not. For those with more than 60% but less than 90% necrosis, specific indications for liver transplantation have been developed empirically and have been shown to be very useful clinically.
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Transplant decision-making Two major systems exist for the identification of those that will require liver transplantation. 2, 3 The simpler of the two is the French system (Table 1) . 3 Only two parameters are considered in this system. These are the patient's age and the factor V level in plasma as confusion and coma are characteristies of FHF phase. The British system actually consists of two separate sets of criteria; one for those with acute hepatic failure secondary to acetaminophen toxicity (Table 2 ) and a second set for all other etiologies of acute hepatic failure (Table 3) . 2 Unlike the French system, a variety of measures are taken into consideration in the British criteria for liver transplantation in patients with acute hepatic failure. Despite the considerable differences in these two systems, little or no difference exists in the efficacy of the two systems in terms of the positive and negative predictive values that can be identified for each. 9 Both systems were developed to predict the need for liver transplantation on admission to the ICU and within 24 h. The reality, however, is that the decision to transplant or not does not have to be made at the time of admission, but, rather, at the time a donor organ has been identified. 5 This is because the typical waiting time for a donor organ for a United Network for Organ Sharing (UNOS) status 1 patient (those with fulminant hepatic failure) is 2-3 days or more.
Liver transplantation
Once a decision is made to transplant a given patient, the surgical options for transplantation come into play. These are shown in Table 4 . The most frequently utilized procedure is cadaveric whole organ transplantation, with the donor organ being placed in the orthotopic position. Alternative procedures that are applicable to children with fulminant hepatic failure are a reduced sized liver graft or split liver transplant. 10, 11 In the former case, a whole cadaveric organ is reduced in size by the removal of segments 2 and 3 or segments 2, 3, and 4 from the whole liver, and the removed segments are transplanted in an orthotopic position in the recipient, while the residual cadaveric organ is discarded. In the second case, a whole cadaveric organ is split into its right and left halves, and the left lobe, or its lateral segment, is transplanted into a child, while the right lobe is transplanted into an adolescent or adult, with both halves of the cadaveric donor organ being used. Thus, in the case of the split liver, two transplants are performed utilizing a single cadaveric organ. To accomplish this feat, as opposed to a reduced size transplant, however, twice the facilities, in terms of operating rooms, recovery rooms, and hospital beds, are required. Moreover, twice as many staff are necessary, in terms of surgeons, anesthesiologists, and intensive care personnel. The additional staff must also have unique expertise in both pediatric and adult hepatic disease, liver transplantation, and post-transplant care.
As for auxiliary transplantation, whole liver heterotopic transplantation was developed first. This procedure has fallen out of favor both because it is technically difficult to do and because there is often insufficient space in the abdomen of the recipient for the donor liver. More recently, auxiliary partial liver transplantation has been developed. 12, 13 In this scenario, a portion of the liver, usually the right lobe, is transplanted in the heterotopic position. Less often, a portion of the liver, typically the left lobe or the left lateral segment, is transplanted in the orthotopic position. The advantage of auxiliary liver transplantation as opposed to orthotopic liver transplantation is that, with recovery of the native liver, immunosuppression can be discontinued. 12 This maneuver leads to rejection and involution of the graft. At times, surgical removal of the graft is accomplished, particularly, if with the cessation of immunosuppression, the graft becomes a source of toxins or becomes infected. Table 2 . British prognostic criteria for individuals with acetaminophen-induced hepatic failure 1. pH (less than 7.30) 2. Prothrombin time (more than 100 s) 3. Serum creatinine (more than 300 µmol/l) 4. Encephalopathy (grade III-IV) Table 3 . British prognostic criteria for individuals with acute hepatic failure (any three of the following criteria)
1. Age (Ͻ10 years or Ͼ40 years) 2. Etiological cause (halothane hepatitis) 3. Jaundice (onset more than 7 days before the onset of encephalopathy) 4. Prothrombin time (greater than 50 s) 5. Serum bilirubin (greater than 300 µmol/l) 6. Encephalopathy (grade III-IV) 5, 6, 7, and 8) In areas of the world such as Japan and the rest of Asia where the concept of brain death has only recently been accepted, and orthotopic liver transplantation has been limited by a lack of cadaveric donors, livingrelated transplantation has been developed and refined as an acceptable alternative transplant procedure. 5, 14 The initial experience with living-related liver transplantation was in children with biliary atresia in whom the native liver was removed and replaced by the left lateral segment of an adult donor, usually a parent. This procedure had little or no hazard for the donor and provided an adequate amount of donor organ for the recipient to recover immediately. With considerable experience with this initial procedure, transplantation of the left lobe into an adult or adolescent from an adult donor has slowly begun to be accomplished. Although the risk to the donor of this expanded resection is greater than that with donation of the left lateral segment, the procedure has sufficiently little risk in expert hands that it has become a widely practiced surgical procedure, particularly in Japan. 14 Unfortunately, for living-related liver transplantation to be successful, a minimum of 30% of the expected mass of the recipient must be removed from the donor and transplanted into the recipient.
14 Ideally, a mass equivalent to 40% or more of the recipient's expected normal liver mass is removed and transplanted. To accomplish this in an adult recipient, it is often necessary to resect the right lobe of the donor to provide sufficient hepatic tissue for the recipient to receive 30% to 40% of their expected hepatic mass. Because of a variety of anatomic issues, a right lobe resection is a considerably greater surgical procedure than is resection of the left lobe or the left lateral segment. As a result, a right lobe resection carries a 1%-3% mortality risk for the donor.
14 This level of risk for the donor of a living-related transplant is considerable indeed, and has limited the willingness of many transplant surgeons to perform the procedure. Nonetheless, the experience with right lobe donation in adult-to-adult liver transplantation has slowly but steadily been expanded to involve more surgeons and more institutions. Because of the considerable Japanese experience with this procedure, the Western world has begun to investigate its use, in highly selected patients, by highly accomplished Western transplant surgeons.
Liver cell transplantation
The use of liver cell transplantation for the treatment of fulminant hepatic failure has not been particularly successful, and may never reach its hoped-for potential, simply because of the number of cells required to be transplanted. 15 As a result, this option was not included in Table 4 . Assuming that a mass of available cells equal to a third of one's expected liver mass is necessary for successful transplantation to occur, and assuming that only a third of the cells harvested for transplantation will survive, the actual volume of cells required for success with liver cell transplantation is equal to that contained in a whole liver. The ability to harvest such a large volume of cells and then infuse them is a logistic nightmare and is likely to make this procedure a rare event, capable of being performed at only a very few highly specialized institutions with a unique interest in its performance.
